DANIELE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 5.837
AS - Asia 2.682
EU - Europa 2.662
SA - Sud America 577
AF - Africa 145
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.911
Nazione #
US - Stati Uniti d'America 5.619
IT - Italia 1.335
SG - Singapore 829
CN - Cina 712
HK - Hong Kong 635
BR - Brasile 504
SE - Svezia 338
CA - Canada 195
DE - Germania 180
VN - Vietnam 176
BG - Bulgaria 170
GB - Regno Unito 168
AT - Austria 88
RU - Federazione Russa 78
FI - Finlandia 72
IN - India 65
CI - Costa d'Avorio 63
FR - Francia 61
TR - Turchia 42
JP - Giappone 33
AR - Argentina 32
KR - Corea 31
NL - Olanda 29
PL - Polonia 26
SN - Senegal 23
IQ - Iraq 22
BD - Bangladesh 21
IE - Irlanda 21
ZA - Sudafrica 18
BE - Belgio 17
ID - Indonesia 15
ES - Italia 14
MX - Messico 14
UA - Ucraina 13
MA - Marocco 12
CH - Svizzera 11
MY - Malesia 11
NG - Nigeria 11
EC - Ecuador 10
LT - Lituania 10
VE - Venezuela 10
PK - Pakistan 8
PT - Portogallo 8
TW - Taiwan 8
CZ - Repubblica Ceca 7
EG - Egitto 7
IL - Israele 7
IR - Iran 7
KZ - Kazakistan 7
UZ - Uzbekistan 7
JO - Giordania 6
OM - Oman 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
LB - Libano 5
UY - Uruguay 5
CO - Colombia 4
PE - Perù 4
PY - Paraguay 4
BJ - Benin 3
BY - Bielorussia 3
NP - Nepal 3
RO - Romania 3
BO - Bolivia 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PS - Palestinian Territory 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BB - Barbados 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KY - Cayman, isole 1
ME - Montenegro 1
MN - Mongolia 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
ZW - Zimbabwe 1
Totale 11.911
Città #
Dallas 644
Hong Kong 630
Ashburn 575
Woodbridge 538
Fairfield 489
Singapore 435
Ann Arbor 430
Houston 363
Santa Clara 349
Chandler 251
Serra 248
Seattle 212
Beijing 211
Milan 180
Cambridge 172
Shanghai 169
Sofia 165
Ottawa 158
Wilmington 153
New York 139
Boardman 102
Los Angeles 92
Pisa 91
Rome 88
Florence 83
Princeton 79
Lawrence 68
Abidjan 63
Vienna 63
Hefei 59
London 53
Medford 53
Munich 47
São Paulo 44
Frankfurt am Main 43
Des Moines 39
Lancaster 39
Ho Chi Minh City 37
Redondo Beach 34
Redwood City 34
Dong Ket 31
Naples 27
Buffalo 26
Chicago 26
Seoul 26
Dearborn 25
Hanoi 25
San Diego 24
Tokyo 24
Dakar 23
Nanjing 23
Warsaw 22
Boulder 21
Bremen 21
Helsinki 21
Istanbul 21
Rio de Janeiro 20
Turku 19
Cascina 18
Marseille 18
Brussels 17
Mendicino 17
Fuzhou 16
Ogden 15
San Francisco 15
San Jose 15
Paris 14
Belo Horizonte 13
Brasília 13
Sligo 13
Council Bluffs 12
Lucca 12
Nuremberg 12
Lagos 11
Tianjin 11
Chennai 10
Orta di Atella 10
Verona 10
Brooklyn 9
Denver 9
Johannesburg 9
Atlanta 8
Bern 8
Cava Dei Tirreni 8
Changsha 8
Guangzhou 8
Shenyang 8
Turin 8
Almaty 7
Düsseldorf 7
Gallarate 7
Izmir 7
Kuala Lumpur 7
Livorno 7
Montreal 7
Montréal 7
Taipei 7
The Dalles 7
Valencia 7
Amman 6
Totale 8.585
Nome #
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 703
Altered Visual Plasticity in Morbidly Obese Subjects 256
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 229
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 201
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 197
Effects of bariatric surgery on brain glucose metabolism and cognitive function: insight from dynamic FDG PET/CT study 196
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 193
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 189
Brain effect of bariatric surgery in people with obesity 185
Exenatide modulates visual cortex responses 181
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 180
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 179
The effects of bariatric surgery on the brain glucose metabolism and its biological mediators: an insight from dynamic 18F-FDG PET/CT study 176
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 173
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 171
Prognostic implications of diabetes phenotyping: new concepts for an old disease 169
Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System 167
Impaired brain plasticity in obesity: effects of bariatric surgery and gut hormones 166
Dapagliflozin lowers plasma glucose concentration and improves β-cell function 165
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus 164
Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line 162
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy 162
Insulin resistance and endothelial dysfunction: A mutual relationship in cardiometabolic risk 162
Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males 161
Effects of Intermittent Fasting on Brain Metabolism 157
Insulin secretion and action affect glucose variability in the early stages of glucose intolerance 155
Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes 152
Ectopic fat: The true culprit linking obesity and cardiovascular disease? 152
Fiber orientation measurements by diffusion tensor imaging improve hydrogen-1 magnetic resonance spectroscopy of intramyocellular lipids in human leg muscles 151
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes 150
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery 147
Effects of Treatment With Metformin and/or Sitagliptin on Beta-cell Function and Insulin Resistance in Prediabetic Women With Previous Gestational Diabetes 146
Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitus 145
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study 143
null 142
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study 142
Association between a metabolic syndrome severity score and all- cause mortality in type 1 diabetes: a 10-year follow-up study 139
I nuovi farmaci per il diabete: gli inibitori del co-trasportatore sodio-glucosio di tipo 2 (SGLT-2i) 138
THE METABOLIC SYNDROME IS RELATED TO ALBUMINURIA IN TYPE 2 DIABETES 135
GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach 135
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 135
Determinants of the Increase in Fasting Plasma Ketone Concentration during SGLT2 Inhibition in NGT, IFG and T2DM Patients 134
Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge 134
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 133
Bariatric surgery restores visual cortical plasticity in nondiabetic subjects with obesity 132
Pioglitazone Inhibits Mitochondrial Pyruvate Metabolism and Glucose Production in Hepatocytes 131
Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes 128
Discordance between central (Brain) and pancreatic action of exenatide in lean and obese subjects 127
Terapia con metformina e rischio di acidosi lattica 125
Cognitive Function and Brain Plasticity in Obese Patients—The Impact of Bariatric Surgery 124
Invited review. Series: Implications of the recent CVOTs in type 2 diabetes: Which patients for GLP-1RA or SGLT-2 inhibitor? 123
Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report 120
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism 118
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 115
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study. diabetes care 2020;43:E139–e141 115
null 115
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 114
β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin 113
Effect of fasting on short-term visual plasticity in adult humans 113
null 108
Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report 106
Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report 99
The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans 99
null 96
Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes 96
Empagliflozin Treatment is Associated with Improved Beta Cell Function in T2DM 96
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion 95
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications 93
Inhibition of Renal Sodium-Glucose Co-Transport with Empagliflozin Lowers Fasting Plasma Glucose and Improves Beta Cell Function in Subjects With Impaired Fasting Glucose 89
Renal Denervation Attenuates Endogenous Glucose Production Increase with SGLT2 Inhibition in Patients with Renal Transplant Recipients and Impaired Fasting Glucose 89
Abnormalities of Insulin Secretion and ß-Cell Defects in Type 2 Diabetes 88
null 84
Access to emergency room for hypoglycaemia in people with diabetes 84
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients 83
null 83
Circulating N-Acetylaspartate does not track brain NAA concentrations, cognitive function or features of small vessel disease in humans 82
Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes 79
Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas 78
null 76
Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant 76
Plasma N-acetylaspartate: development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization 75
Near-Infrared Spectroscopy: A Free-Living Neuroscience Tool to Better Understand Diabetes and Obesity 75
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production 68
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals 64
null 63
Treatment with Oral Drugs 63
null 60
What are the pharmacotherapy options for treating prediabetes? 53
null 48
The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus 40
null 32
Skipping breakfast changes visual processing: incretins contribution to short-term visual plasticity 20
Acute Supplementation of Beta-Hydroxybutyrate Increases Visual Cortical Excitability in Humans: A Combined Electro-EncephaloGraphy and Magnetic Resonance Spectroscopy Study 13
GLP ‐1 receptor agonist therapy for relapsed diabetes following 6q24‐related transient neonatal diabetes due to paternal uniparental disomy: A case report 1
Is It Worth Assessing the Prevalence of Sarcopenia in Pregnant Women? Should Any Impact on Pregnancy Outcomes Be Expected? 1
Circulating N-Acetylaspartate Levels Associate with Measures of Peripheral and Tissue-Specific Insulin Sensitivity 1
Current treatment for diabetes: a holistic approach 1
Totale 12.122
Categoria #
all - tutte 34.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021432 0 0 0 0 0 0 36 97 67 83 55 94
2021/2022770 19 42 20 33 143 112 30 31 46 25 48 221
2022/20231.160 142 171 102 85 83 127 26 99 209 9 83 24
2023/2024907 75 92 89 70 124 128 64 25 23 54 61 102
2024/20253.089 66 122 86 167 278 309 317 169 295 432 289 559
2025/20262.376 226 437 701 375 358 267 12 0 0 0 0 0
Totale 12.122